Q32 Bio (QTTB) Equity Ratio (2017 - 2026)

Q32 Bio's Equity Ratio history runs 10 years deep, the most recent figure standing at 0.73 for Q1 2026.

• In Q1 2026, Equity Ratio rose 1532.76% year-over-year to 0.73; the TTM figure through Mar 2026 stood at 0.73 (up 1532.76% YoY), while the FY2025 annual figure was 0.68, up 1006.52% from the prior year.
• Equity Ratio was 0.73 for Q1 2026 at Q32 Bio, up from 0.68 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.86 in Q1 2022 to a low of 3.89 in Q4 2023.
• Historically, Equity Ratio has averaged 0.17 across 5 years, with a median of 0.06 in 2024.
• The sharpest annual moves came in 2023 and 2026: Equity Ratio slumped 579.44% in 2023, then surged 1532.76% in 2026.
• A 5-year view of Equity Ratio shows it stood at 0.57 in 2022, then plunged by 579.44% to 3.89 in 2023, then surged by 101.58% to 0.06 in 2024, then surged by 1006.52% to 0.68 in 2025, then grew by 6.94% to 0.73 in 2026.
• The last three Equity Ratio figures came in at 0.73 (Q1 2026), 0.68 (Q4 2025), and 0.32 (Q3 2025), per Business Quant data.